Nano sensors has offering unprecedented precision and sensitivity in detecting and monitoring biological processes at the nanoscale. These miniature devices, typically ranging from 1 to 100 nanometers in size, exhibit unique properties that make them ideal for applications in drug development, diagnostics, and therapeutic monitoring. In the pharmaceutical industry, nano sensors play a crucial role in enhancing the understanding of cellular and molecular mechanisms, allowing for the design of more targeted and efficient drug delivery systems. These sensors can detect subtle changes in biomarkers, enabling early diagnosis of diseases and personalized treatment strategies.
Additionally, nano sensors contribute to the advancement of pharmacokinetics by providing real-time data on drug interactions within the body, optimizing dosages, and minimizing side effects. Their ability to navigate biological barriers at the molecular level opens up new possibilities for delivering drugs to specific cells or tissues. As the field of nanotechnology continues to evolve, nano sensors hold the promise of transforming the pharmaceutical landscape by providing innovative solutions for diagnosis, treatment, and monitoring of various medical conditions.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand